Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023

移植診断の世界市場予測(~2023年)

◆タイトル:Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023
◆商品コード:MD4870
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年6月29日
◆ページ数:222
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、移植診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別(PCR、NGS、サンガー法シーケンシング)分析、製品別(機器、試薬、ソフトウェア)分析、用途別(HLA、血液プロファイリング、病原体検出)分析、タイプ別(心臓、腎臓、肝臓、幹細胞)分析、移植診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The transplant diagnostics market projected to grow at a CAGR of 7.4%.”The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.
“The molecular assay technologies segment is poised to be the fastest-growing during the forecast period.”
On the basis of technology, the transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such as low turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.

“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

The global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements, & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the major players in the transplant diagnostics market. The report analyzes the transplant diagnostics market based on technology, product, transplant type, application, end user, and region
• Product Development: Detailed insights on the research and development activities and product launches in the transplant diagnostics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transplant diagnostics market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transplant diagnostics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 GEOGRAPHIC SCOPE 20
1.3.3 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY USED FOR THE STUDY 21
1.5 MAJOR MARKET STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.2 PRIMARY DATA 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 PRODUCT-BASED MARKET ESTIMATION 25
2.2.2 PROCEDURE BASED MARKET ESTIMATION 25
2.2.3 PRIMARY RESEARCH VALIDATION 26
2.3 DATA TRIANGULATION 27
2.4 RESEARCH ASSUMPTIONS 28
2.5 RESEARCH LIMITATIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 36
4.1 TRANSPLANT DIAGNOSTICS MARKET OVERVIEW 36
4.2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 37
4.3 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 38
4.4 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2018 39
4.5 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 40
4.6 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 41
4.7 TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 42

5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
5.2.1 KEY MARKET DRIVERS 44
5.2.1.1 Increasing number of transplant procedures 44
5.2.1.2 Technological advancements in the field of transplant diagnostics 45
5.2.1.3 Increasing public-private funding for target research activities 46
5.2.1.4 Growing burden of infectious diseases 47
5.2.2 KEY MARKET RESTRAINTS 47
5.2.2.1 High procedural cost of NGS and PCR-based diagnostic assays 47
5.2.2.2 Limited reimbursements for target procedures 48
5.2.3 KEY MARKET OPPORTUNITIES 49
5.2.3.1 Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation 49
5.2.3.2 Increasing public awareness about organ donation and transplantation across emerging countries 49
5.2.4 KEY MARKET CHALLENGES 50
5.2.4.1 Significant gap between the number of organ donors and organs required annually 50
5.2.4.2 Procedural and technical limitations associated with donor-recipient screening 51
6 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES 52
6.1 INTRODUCTION 53
6.2 REAGENTS AND CONSUMABLES 54
6.3 INSTRUMENTS 55
6.4 SOFTWARE AND SERVICES 56
7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 MOLECULAR ASSAYS 61
7.2.1 PCR-BASED MOLECULAR ASSAYS 62
7.2.1.1 REAL-TIME PCR 65
7.2.1.2 Sequence-specific primer-PCR 66
7.2.1.3 Sequence-specific oligonucleotide-PCR 67
7.2.1.4 Other PCR-based molecular assays 68
7.2.2 SEQUENCING-BASED MOLECULAR ASSAYS 69
7.2.2.1 Sanger sequencing 72
7.2.2.2 Next-generation sequencing 73
7.2.2.3 Other sequencing molecular assays 74
7.3 NON-MOLECULAR ASSAYS 75

8 TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 78
8.1 INTRODUCTION 79
8.2 SOLID ORGAN TRANSPLANTATION 80
8.2.1 KIDNEY TRANSPLANTATION 82
8.2.2 LIVER TRANSPLANTATION 83
8.2.3 HEART TRANSPLANTATION 84
8.2.4 LUNG TRANSPLANTATION 85
8.2.5 PANCREAS TRANSPLANTATION 86
8.2.6 OTHER ORGAN TRANSPLANTATIONS 87
8.3 STEM CELL TRANSPLANTATION 87
8.4 SOFT TISSUE TRANSPLANTATION 89
9 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 90
9.1 INTRODUCTION 91
9.2 DIAGNOSTIC APPLICATIONS 91
9.2.1 PRE-TRANSPLANTATION DIAGNOSTICS 93
9.2.1.1 Infectious disease testing 95
9.2.1.2 Histocompatibility testing 96
9.2.1.3 Blood profiling 97
9.2.2 POST-TRANSPLANTATION DIAGNOSTICS 98
9.3 RESEARCH APPLICATIONS 99
10 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 101
10.1 INTRODUCTION 102
10.2 INDEPENDENT REFERENCE LABORATORIES 103
10.3 HOSPITALS & TRANSPLANT CENTERS 105
10.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 106
11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 108
11.1 INTRODUCTION 109
11.2 NORTH AMERICA 110
11.2.1 US 116
11.2.2 CANADA 118
11.3 EUROPE 120
11.3.1 GERMANY 126
11.3.2 UK 127
11.3.3 FRANCE 130
11.3.4 REST OF EUROPE 132

11.4 ASIA PACIFIC 134
11.4.1 JAPAN 139
11.4.2 CHINA 141
11.4.3 INDIA 143
11.4.4 REST OF ASIA PACIFIC 144
11.5 REST OF THE WORLD 146
12 COMPETITIVE LANDSCAPE 152
12.1 OVERVIEW 152
12.2 MARKET SHARE ANALYSIS 153
12.3 COMPETITIVE SCENARIO 154
12.3.1 KEY PRODUCT LAUNCHES AND ENHANCEMENTS (2014 TO 2018) 154
12.3.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014 TO 2018) 155
12.3.3 MAJOR ACQUISITIONS (2014 TO 2018) 155
12.3.4 KEY EXPANSIONS (2014 TO 2018) 156
13 COMPANY PROFILES 157
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 INTRODUCTION 157
13.2 BECTON, DICKINSON AND COMPANY 158
13.3 BIOFORTUNA 161
13.4 BIOMÉRIEUX SA 163
13.5 BIO-RAD LABORATORIES 166
13.6 CAREDX 171
13.7 F. HOFFMAN-LA ROCHE LIMITED 174
13.8 GENDX 178
13.9 HOLOGIC 180
13.10 ILLUMINA 182
13.11 IMMUCOR 186
13.12 LUMINEX 191
13.13 MERCK KGAA 194
13.14 OMIXON 196
13.15 QIAGEN 198
13.16 THERMO FISHER SCIENTIFIC 205
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 211
14.1 DISCUSSION GUIDE 211
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 217
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 219
14.4 AVAILABLE CUSTOMIZATIONS 219
14.5 RELATED REPORTS 220
14.6 AUTHOR DETAILS 221

LIST OF TABLES

TABLE 1 PUBLIC-PRIVATE INVESTMENTS AND RESEARCH GRANTS FOR THE DEVELOPMENT OF TRANSPLANT DIAGNOSTIC PRODUCTS, 2015–2018 46
TABLE 2 COST OF ASSAYS FOR MAJOR NGS/PCR-BASED GENOMIC TESTS IN EUROPE
(AS OF 2014) 47
TABLE 3 MEDICAL REIMBURSEMENTS FOR TRANSPLANTATION PROCEDURES
IN THE US (2017) 49
TABLE 4 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICES,
2016–2023 (USD MILLION) 53
TABLE 5 TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS AND CONSUMABLES,
BY REGION, 2016–2023 (USD MILLION) 55
TABLE 6 TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION,
2016–2023 (USD MILLION) 56
TABLE 7 TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 8 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 59
TABLE 9 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY TYPE,
2016–2023 (USD MILLION) 61
TABLE 10 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY REGION, 2016–2023 (USD MILLION) 62
TABLE 11 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS,
BY TYPE, 2016–2023 (USD MILLION) 63
TABLE 12 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS,
BY PRODUCT, 2016–2023 (USD MILLION) 63
TABLE 13 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS,
BY APPLICATION, 2016–2023 (USD MILLION) 64
TABLE 14 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS,
BY END USER, 2016–2023 (USD MILLION) 64
TABLE 15 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS,
BY REGION, 2016–2023 (USD MILLION) 65
TABLE 16 TRANSPLANT DIAGNOSTICS MARKET FOR REAL-TIME PCR, BY REGION,
2016–2023 (USD MILLION) 66
TABLE 17 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC PRIMER-PCR,
BY REGION, 2016–2023 (USD MILLION) 67
TABLE 18 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, BY REGION, 2016–2023 (USD MILLION) 68
TABLE 19 TRANSPLANT DIAGNOSTICS MARKET FOR OTHER PCR-BASED MOLECULAR ASSAYS, BY REGION, 2016–2023 (USD MILLION) 69
TABLE 20 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 70
TABLE 21 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY PRODUCT, 2016–2023 (USD MILLION) 70
TABLE 22 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY APPLICATION, 2016–2023 (USD MILLION) 71
TABLE 23 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY END USER, 2016–2023 (USD MILLION) 71
TABLE 24 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2016–2023 (USD MILLION) 72
TABLE 25 TRANSPLANT DIAGNOSTICS MARKET FOR SANGER SEQUENCING, BY REGION, 2016–2023 (USD MILLION) 73
TABLE 26 TRANSPLANT DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY REGION, 2016–2023 (USD MILLION) 74
TABLE 27 TRANSPLANT DIAGNOSTICS MARKET FOR OTHER SEQUENCING MOLECULAR ASSAYS, BY REGION, 2016–2023 (USD MILLION) 75
TABLE 28 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY PRODUCT, 2016–2023 (USD MILLION) 76
TABLE 29 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS,
BY APPLICATION, 2016–2023 (USD MILLION) 76
TABLE 30 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS,
BY END USER, 2016–2023 (USD MILLION) 77
TABLE 31 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY REGION, 2016–2023 (USD MILLION) 77
TABLE 32 TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE,
2016–2023 (USD MILLION) 79
TABLE 33 SOLID ORGAN TRANSPLANTATION MARKET, BY TYPE, 2016–2023 (USD MILLION) 81
TABLE 34 SOLID ORGAN TRANSPLANTATION MARKET, BY REGION,
2016–2023 (USD MILLION) 81
TABLE 35 KIDNEY TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 82
TABLE 36 LIVER TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 83
TABLE 37 HEART TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 38 LUNG TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 85
TABLE 39 PANCREAS TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 86
TABLE 40 OTHER ORGAN TRANSPLANTATIONS MARKET, BY REGION,
2016–2023 (USD MILLION) 87
TABLE 41 STEM CELL TRANSPLANTATION MARKET, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 42 SOFT TISSUE TRANSPLANTATION MARKET, BY REGION,
2016–2023 (USD MILLION) 89
TABLE 43 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 91
TABLE 44 TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 92
TABLE 45 TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 92
TABLE 46 TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY TYPE, 2016–2023 (USD MILLION) 94
TABLE 47 TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016–2023 (USD MILLION) 94
TABLE 48 TRANSPLANT DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING,
BY REGION, 2016–2023 (USD MILLION) 95
TABLE 49 TRANSPLANT DIAGNOSTICS MARKET FOR HISTOCOMPATIBILITY TESTING,
BY REGION, 2016–2023 (USD MILLION) 97
TABLE 50 TRANSPLANT DIAGNOSTICS MARKET FOR BLOOD PROFILING, BY REGION,
2016–2023 (USD MILLION) 98
TABLE 51 TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016–2023 (USD MILLION) 99
TABLE 52 TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 100
TABLE 53 TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 102
TABLE 54 TRANSPLANT DIAGNOSTICS MARKET FOR INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 104
TABLE 55 TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2016–2023 (USD MILLION) 106
TABLE 56 TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION) 107
TABLE 57 TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 109
TABLE 58 TOTAL NUMBER OF SOLID ORGAN TRANSPLANTATIONS ACROSS
KEY COUNTRIES (2016) 110
TABLE 59 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 111
TABLE 60 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 111
TABLE 61 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 62 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 63 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016–2023 (USD MILLION) 112
TABLE 64 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 113
TABLE 65 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016–2023 (USD MILLION) 113
TABLE 66 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 114
TABLE 67 US: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 117
TABLE 68 US: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 117
TABLE 69 US: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 118
TABLE 70 CANADA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 119
TABLE 71 CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 119
TABLE 72 CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 120
TABLE 73 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 121
TABLE 74 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 121
TABLE 75 EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 122
TABLE 76 EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 122
TABLE 77 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016–2023 (USD MILLION) 123
TABLE 78 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 123
TABLE 79 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE,
2016–2023 (USD MILLION) 124
TABLE 80 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 124
TABLE 81 GERMANY: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 126
TABLE 82 GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 83 GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 84 ORGAN TRANSPLANTATIONS PERFORMED IN THE UK, 2013 VS. 2015 128
TABLE 85 UK: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 128
TABLE 86 UK: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 87 UK: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 88 FRANCE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 130
TABLE 89 FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 131
TABLE 90 FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 131
TABLE 91 ROE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 132
TABLE 92 ROE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 93 ROE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 94 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 134
TABLE 95 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 134
TABLE 96 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 135
TABLE 97 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 135
TABLE 98 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016–2023 (USD MILLION) 136
TABLE 99 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 136
TABLE 100 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE,
2016–2023 (USD MILLION) 137
TABLE 101 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 137
TABLE 102 JAPAN: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 139
TABLE 103 JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 140
TABLE 104 JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 140
TABLE 105 ORGAN TRANSPLANTATIONS PERFORMED IN CHINA,
2013 VS. 2015 141
TABLE 106 CHINA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 141
TABLE 107 CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 142
TABLE 108 CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 142
TABLE 109 INDIA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 143
TABLE 110 INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 111 INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 112 SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN THE ROAPAC, 2013 VS. 2016 144
TABLE 113 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 145
TABLE 114 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 145
TABLE 115 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 116 ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 148
TABLE 117 ROW: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 148
TABLE 118 ROW: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016–2023 (USD MILLION) 149
TABLE 119 ROW: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES,
2016–2023 (USD MILLION) 149
TABLE 120 ROW: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 150
TABLE 121 ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE,
2016–2023 (USD MILLION) 150
TABLE 122 ROW: TRANSPLANT DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 151




LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL TRANSPLANT DIAGNOSTICS MARKET 24
FIGURE 3 MARKET SIZE ESTIMATION: TRANSPLANT DIAGNOSTICS MARKET 26
FIGURE 4 DATA TRIANGULATION METHODOLOGY 27
FIGURE 5 REAGENTS AND CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2023 29
FIGURE 6 SEQUENCE-SPECIFIC OLIGONUCLEOTIDES-PCR SEGMENT WILL CONTINUE TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET IN 2023 30
FIGURE 7 SOLID ORGAN TRANSPLANTATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2018 31
FIGURE 8 INFECTIOUS DISEASE TESTING SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2018 32
FIGURE 9 INDEPENDENT REFERENCE LABORATORIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 33
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE TRANSPLANT DIAGNOSTICS MARKET 34
FIGURE 11 GROWTH IN TRANSPLANTATION PROCEDURES TO DRIVE THE DEMAND FOR TRANSPLANT DIAGNOSTIC PRODUCTS TILL 2023 36
FIGURE 12 PCR-BASED MOLECULAR ASSAYS TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, DURING THE FORECAST PERIOD 37
FIGURE 13 INFECTIOUS DISEASE TESTING AND HISTOCOMPATIBILITY TESTING SEGMENTS TO WITNESS HIGH GROWTH IN THE ASIA PACIFIC MARKET 38
FIGURE 14 INDEPENDENT REFERENCE LABORATORIES WILL DOMINATE THE ASIA PACIFIC TRANSPLANT DIAGNOSTICS END-USER MARKET IN 2018 39
FIGURE 15 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST MARKET FOR ALL PRODUCTS & SERVICES SEGMENTS IN THE TRANSPLANT DIAGNOSTICS MARKET IN 2018 40
FIGURE 16 KIDNEY TRANSPLANTATION SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 41
FIGURE 17 CHINA AND INDIA IS ESTIMATED TO BE THE FASTEST-GROWING TRANSPLANT DIAGNOSTICS MARKET 42
FIGURE 18 TRANSPLANT DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
FIGURE 19 SOLID ORGAN TRANSPLANTATION PROCEDURES PERFORMED ACROSS MAJOR COUNTRIES, 2016 44
FIGURE 20 REAGENTS & CONSUMABLES TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD (2018–2023) 54
FIGURE 21 PCR-BASED MOLECULAR ASSAYS SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 60
FIGURE 22 KIDNEY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANT DIAGNOSTICS MARKET IN 2018 80
FIGURE 23 INFECTIOUS DISEASE TESTING TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 93
FIGURE 24 INDEPENDENT REFERENCE LABORATORIES TO REGISTER THE HIGHEST CAGR IN THE TRANSPLANT DIAGNOSTICS MARKET DURING 2018–2023 103
FIGURE 25 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018–2023) 115
FIGURE 26 SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN THE US, 2013–2017 116
FIGURE 27 TISSUE TRANSPLANTATIONS PERFORMED IN THE US, 2013–2017 116
FIGURE 28 SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN CANADA, 2015 VS. 2016 118
FIGURE 29 EUROPE: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018–2023) 125
FIGURE 30 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018–2023) 138
FIGURE 31 SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN JAPAN, 2013 TO 2017 139
FIGURE 32 ROW: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018–2023) 147
FIGURE 33 PRODUCT LAUNCHES AND ENHANCEMENTS, KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2014 TO 2018 152
FIGURE 34 BIO-RAD LABORATORIES HELD THE LEADING POSITION IN THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET AS OF 2017 153
FIGURE 35 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS (2017) 157
FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017) 158
FIGURE 37 BIOMERIEUX: COMPANY SNAPSHOT (2017) 163
FIGURE 38 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017) 166
FIGURE 39 CAREDX: COMPANY SNAPSHOT (2017) 171
FIGURE 40 F. HOFFMAN-LA ROCHE LIMITED: COMPANY SNAPSHOT (2017) 174
FIGURE 41 HOLOGIC: COMPANY SNAPSHOT (2017) 180
FIGURE 42 ILLUMINA: COMPANY SNAPSHOT (2017) 182
FIGURE 43 IMMUCOR: COMPANY SNAPSHOT (2016) 186
FIGURE 44 LUMINEX: COMPANY SNAPSHOT (2017) 191
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2017) 194
FIGURE 46 QIAGEN: COMPANY SNAPSHOT (2017) 198
FIGURE 47 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 205




★調査レポート[移植診断の世界市場予測(~2023年)] ( Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023 / MD4870) 販売に関する免責事項
[移植診断の世界市場予測(~2023年)] ( Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023 / MD4870) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆